{"therapeaticArea": {"id": "7971305f-ccb0-424c-8bee-08b34e209a2a", "language": "en", "title": "Rheumatology", "machineName": "rheumatology", "displayName": "Rheumatology", "listAccess": "public"}, "products": {"42b25c0c-a464-42a0-8f71-f1de0d7cbc3e": {"id": "42b25c0c-a464-42a0-8f71-f1de0d7cbc3e", "title": "Xeljanz\u00ae", "displayName": "Xeljanz\u00ae", "machineName": "42b25c0c-a464-42a0-8f71-f1de0d7cbc3e", "genericName": "Tofacitinib", "piRmm": "<p><a href=\"http://labeling.pfizer.com/ShowLabeling.aspx?id=959\" target=\"_blank\">Prescribing Information including BOXED WARNING</a></p>\r\n", "count": 12}, "f91c64fd-d33d-4b0a-8956-31aaccab251c": {"id": "f91c64fd-d33d-4b0a-8956-31aaccab251c", "title": "Inflectra\u00ae", "displayName": "Inflectra\u00ae", "machineName": "f91c64fd-d33d-4b0a-8956-31aaccab251c", "genericName": "Infliximab-dyyb", "piRmm": "<p><a href=\"http://labeling.pfizer.com/ShowLabeling.aspx?id=9271\" target=\"_blank\">Prescribing Information including BOXED WARNING</a></p>\r\n", "count": 2}}, "disease_state": {"e57becc6-7981-4190-a9f9-778f1fd186e7": {"id": "e57becc6-7981-4190-a9f9-778f1fd186e7", "title": "JIA", "machineName": "e57becc6-7981-4190-a9f9-778f1fd186e7", "genericName": null, "displayName": "JIA", "count": 1}, "e805c3d5-56f2-4381-8e11-65a6fb4a3aff": {"id": "e805c3d5-56f2-4381-8e11-65a6fb4a3aff", "title": "Ankylosing Spondylitis Rheumatology", "machineName": "e805c3d5-56f2-4381-8e11-65a6fb4a3aff", "genericName": null, "displayName": "Ankylosing Spondylitis", "count": 2}, "f995aeff-7dc2-455c-900d-bb9783546571": {"id": "f995aeff-7dc2-455c-900d-bb9783546571", "title": "Psoriatic Arthritis", "machineName": "f995aeff-7dc2-455c-900d-bb9783546571", "genericName": null, "displayName": "Psoriatic Arthritis", "count": 4}, "29b16619-52ef-4503-974b-a96c80bdbaa3": {"id": "29b16619-52ef-4503-974b-a96c80bdbaa3", "title": "Rheumatoid Arthritis Rheumatology", "machineName": "29b16619-52ef-4503-974b-a96c80bdbaa3", "genericName": null, "displayName": "Rheumatoid Arthritis", "count": 7}}, "data": {"results": [{"id": "26795e73-515a-4ad3-b78a-f2c8c6849fa0", "language": "en", "title": "Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641266", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01255-1/fulltext", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "November 9, 2021", "publishDateUnformatted": "2021-11-09"}, "createdDate": "1638435200", "assets": {"previewImage": []}, "diseaseState": ["e57becc6-7981-4190-a9f9-778f1fd186e7"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Ruperto N et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The Lancet", "kicker": "November 9, 2021 | The Lancet", "publishedUnformattedDate": "2021-11-09", "recent_kicker": "Publications"}, {"id": "ed8b06e0-3829-4509-8756-bf8ff901b32f", "language": "en", "title": "Tofacitinib for the treatment of ankylosing spondylitis: a Phase III, randomised, double-blind, placebo-controlled study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645640464", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://ard.bmj.com/content/early/2021/04/26/annrheumdis-2020-219601", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "April 27, 2021", "publishDateUnformatted": "2021-04-27"}, "createdDate": "1638428289", "assets": {"previewImage": []}, "diseaseState": ["e805c3d5-56f2-4381-8e11-65a6fb4a3aff"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Deodhar A et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Annals of the Rheumatic Diseases", "kicker": "April 27, 2021 | Annals of the Rheumatic Diseases", "publishedUnformattedDate": "2021-04-27", "recent_kicker": "Publications"}, {"id": "275f40a3-7e5f-4831-aaa4-d1b0db9f5d05", "language": "en", "title": "Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641142", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00010-2/fulltext", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "April 25, 2021", "publishDateUnformatted": "2021-04-25"}, "createdDate": "1638263485", "assets": {"previewImage": []}, "diseaseState": ["f995aeff-7dc2-455c-900d-bb9783546571"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Nash P et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The Lancet Rheumatology", "kicker": "April 25, 2021 | The Lancet Rheumatology", "publishedUnformattedDate": "2021-04-25", "recent_kicker": "Publications"}, {"id": "d9452814-52d5-4e53-bc01-48645fe597f0", "language": "en", "title": "Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641014", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30339-8/fulltext", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "November 16, 2020", "publishDateUnformatted": "2020-11-16"}, "createdDate": "1638262983", "assets": {"previewImage": []}, "diseaseState": ["f995aeff-7dc2-455c-900d-bb9783546571"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Nash P et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The Lancet Rheumatology", "kicker": "November 16, 2020 | The Lancet Rheumatology", "publishedUnformattedDate": "2020-11-16", "recent_kicker": "Publications"}, {"id": "269fc176-09c3-49bf-9237-aa4d694f5ad4", "language": "en", "title": "Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studies", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": false, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1651219211", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://pubmed.ncbi.nlm.nih.gov/32271970/", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "reactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "July 16, 2020", "publishDateUnformatted": "2020-07-16"}, "createdDate": "1650535521", "assets": {"previewImage": []}, "diseaseState": ["f995aeff-7dc2-455c-900d-bb9783546571"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Merola JF et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Journal of the European Academy of Dermatology and Venereology", "kicker": "July 16, 2020 | Journal of the European Academy of Dermatology and Venereology", "publishedUnformattedDate": "2020-07-16", "recent_kicker": "Publications"}, {"id": "cd375d9c-9ea5-4432-a0a8-dfe1dafbd731", "language": "en", "title": "Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": false, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1651219338", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://pubmed.ncbi.nlm.nih.gov/30953540/", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "reactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "April 5, 2019", "publishDateUnformatted": "2019-04-05"}, "createdDate": "1650536004", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Wollenhaupt J et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Arthritis Research and Therapy", "kicker": "April 5, 2019 | Arthritis Research and Therapy", "publishedUnformattedDate": "2019-04-05", "recent_kicker": "Publications"}, {"id": "68670c8c-d25b-4d66-a8c1-6f57ae2825ea", "language": "en", "title": "Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641402", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://www.nejm.org/doi/full/10.1056/NEJMoa1615977?query=TOC", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "October 19, 2017", "publishDateUnformatted": "2017-10-19"}, "createdDate": "1638262449", "assets": {"previewImage": []}, "diseaseState": ["f995aeff-7dc2-455c-900d-bb9783546571"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Gladman D et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The New England Journal of Medicine", "kicker": "October 19, 2017 | The New England Journal of Medicine", "publishedUnformattedDate": "2017-10-19", "recent_kicker": "Publications"}, {"id": "474efcae-c82d-45de-948d-8a4468441cb6", "language": "en", "title": "Tofacitinib or adalimumab versus placebo for psoriatic arthritis", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645649769", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://www.nejm.org/doi/full/10.1056/NEJMoa1615975?query=TOC", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "October 19, 2017", "publishDateUnformatted": "2017-10-19"}, "createdDate": "1638192918", "assets": {"previewImage": []}, "diseaseState": ["f995aeff-7dc2-455c-900d-bb9783546571"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Mease P et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The New England Journal of Medicine", "kicker": "October 19, 2017 | The New England Journal of Medicine", "publishedUnformattedDate": "2017-10-19", "recent_kicker": "Publications"}, {"id": "ea995cc9-bbf1-4a6d-a8b7-cc8001c6d94b", "language": "en", "title": "Tofacitinib versus methotrexate in rheumatoid arthritis", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641404", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://www.nejm.org/doi/full/10.1056/NEJMoa1310476", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "June 19, 2014", "publishDateUnformatted": "2014-06-19"}, "createdDate": "1638434331", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Lee EB et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The New England Journal of Medicine", "kicker": "June 19, 2014 | The New England Journal of Medicine", "publishedUnformattedDate": "2014-06-19", "recent_kicker": "Publications"}, {"id": "e91f1797-e732-46d2-aecd-106d22b0d37a", "language": "en", "title": "Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645640475", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://www.acpjournals.org/doi/10.7326/0003-4819-159-4-201308200-00006?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "August 20, 2013", "publishDateUnformatted": "2013-08-20"}, "createdDate": "1638434926", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Kremer J et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Annals of Internal Medicine", "kicker": "August 20, 2013 | Annals of Internal Medicine", "publishedUnformattedDate": "2013-08-20", "recent_kicker": "Publications"}, {"id": "0ffd5c8a-dbd5-4a85-aaa3-6a1858dd4db9", "language": "en", "title": "A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645640339", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://ard-bmj-com.eu1.proxy.openathens.net/content/72/10/1613.long", "pdfUpload": null, "visibility": "public", "promotionalStatus": null, "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "May 16, 2013", "publishDateUnformatted": "2013-05-16"}, "createdDate": "1638435658", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["f91c64fd-d33d-4b0a-8956-31aaccab251c"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Yoo DH et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Annals of the Rheumatic Diseases", "kicker": "May 16, 2013 | Annals of the Rheumatic Diseases", "publishedUnformattedDate": "2013-05-16", "recent_kicker": "Publications"}, {"id": "e96b9975-7a7a-47b2-9ad9-badf59fe4379", "language": "en", "title": "A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641012", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://ard-bmj-com.eu1.proxy.openathens.net/content/72/10/1605.long", "pdfUpload": null, "visibility": "public", "promotionalStatus": null, "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "May 16, 2013", "publishDateUnformatted": "2013-05-16"}, "createdDate": "1638435398", "assets": {"previewImage": []}, "diseaseState": ["e805c3d5-56f2-4381-8e11-65a6fb4a3aff"], "medicalInsightProducts": ["f91c64fd-d33d-4b0a-8956-31aaccab251c"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Park W et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Annals of the Rheumatic Diseases", "kicker": "May 16, 2013 | Annals of the Rheumatic Diseases", "publishedUnformattedDate": "2013-05-16", "recent_kicker": "Publications"}, {"id": "f6833add-3365-48da-81de-3433e1b801a4", "language": "en", "title": "Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four\u2013month phase III randomized radiographic study", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645641149", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://onlinelibrary.wiley.com/doi/10.1002/art.37816/abstract", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "January 24, 2013", "publishDateUnformatted": "2013-01-24"}, "createdDate": "1638433107", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Van der Heijde D et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "Arthritis & Rheumatology", "kicker": "January 24, 2013 | Arthritis & Rheumatology", "publishedUnformattedDate": "2013-01-24", "recent_kicker": "Publications"}, {"id": "78dbd48f-a81b-4f0c-a062-2ab2491e0c73", "language": "en", "title": "Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645640735", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61424-X/abstract", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "January 5, 2013", "publishDateUnformatted": "2013-01-05"}, "createdDate": "1638433985", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Burmester GR et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The Lancet", "kicker": "January 5, 2013 | The Lancet", "publishedUnformattedDate": "2013-01-05", "recent_kicker": "Publications"}, {"id": "eafe1fa5-478e-476a-a806-e56278659f43", "language": "en", "title": "Tofacitinib or adalimumab versus placebo in rheumatoid arthritis", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645640605", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "http://www.nejm.org/doi/full/10.1056/NEJMoa1112072?query=TOC", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "August 9, 2012", "publishDateUnformatted": "2012-08-09"}, "createdDate": "1638433794", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>van Vollenhoven RF et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The New England Journal of Medicine", "kicker": "August 9, 2012 | The New England Journal of Medicine", "publishedUnformattedDate": "2012-08-09", "recent_kicker": "Publications"}, {"id": "41f5950a-956b-4325-89c0-1d84cdf120ae", "language": "en", "title": "Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis", "featured": null, "market": "us", "type": "medical_insight_media", "tags": null, "listAccess": null, "jobBagNumber": null, "jobBagDate": null, "published": true, "brands": null, "therapeuticAreas": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "lastUpdatedDate": "1645710677", "mediaType": {"key": "pdf", "label": "PDF"}, "link": "https://www-nejm-org.eu1.proxy.openathens.net/doi/10.1056/NEJMoa1109071?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov", "pdfUpload": null, "visibility": "public", "promotionalStatus": "promotional", "reactiveStatus": "proactive", "medicalMenuCategory": {"uuid": ["f86bd736-ae5f-4fc0-933a-d6abed53f4f4"], "displayName": ["Publications"], "slug": ["publications"]}, "dates": {"publishDateFormatted": null, "publishDate": "August 9, 2012", "publishDateUnformatted": "2012-08-09"}, "createdDate": "1638432803", "assets": {"previewImage": []}, "diseaseState": ["29b16619-52ef-4503-974b-a96c80bdbaa3"], "medicalInsightProducts": ["42b25c0c-a464-42a0-8f71-f1de0d7cbc3e"], "searchKeywords": [], "therapeuticArea": {"uuid": ["7971305f-ccb0-424c-8bee-08b34e209a2a"], "displayName": ["Rheumatology"]}, "piRmm": null, "authors": "<p>Fleischmann R et al</p>\r\n", "summary": null, "description": null, "legalDisclaimer": null, "publicationType": "Manuscript", "journal": "The New England Journal of Medicine", "kicker": "August 9, 2012 | The New England Journal of Medicine", "publishedUnformattedDate": "2012-08-09", "recent_kicker": "Publications"}]}}